Rating Change
Barclays analysts upgraded Qiagen N.V. (NYSE:QGEN) from Equal-Weight to Overweight on October 06, 2026.
upgradeNYSE:QGEN
Qiagen N.V. (QGEN) Upgraded to Overweight at Barclays
Barclays analysts upgraded Qiagen N.V. (NYSE:QGEN) from Equal-Weight to Overweight on October 06, 2026.
At publication ·
What changed
Qiagen N.V. (NYSE:QGEN) · upgrade
- Firm
- Barclays
- Rating
- Equal-Weight to Overweight
- Price at event
- $45.65
- Market capitalization
- $9.8B
At a glance
Key takeaways
- Barclays upgraded Qiagen from Equal-Weight to Overweight on October 6, 2026, suggesting analysts see improving fundamentals or favorable catalysts.
Market Context
Qiagen N.V. operates in the Healthcare sector. The stock currently trades at $45.65 with a market capitalization of $9.8B. The stock has declined 2.2% over the past 52 weeks.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Barclays's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Qiagen N.V.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 06, 2026 | Barclays | Overweight | N/A |
| Sep 09, 2026 | UBS | Neutral | N/A |
| Aug 10, 2026 | Citigroup | Neutral | N/A |
| Aug 07, 2026 | JP Morgan | Overweight | N/A |
| Aug 07, 2026 | Barclays | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View QGEN Stock Page
Frequently Asked Questions
What does the Overweight rating mean for QGEN?
A rating of Overweight from Barclays reflects the analyst's outlook on Qiagen N.V. (NYSE:QGEN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the QGEN forecast page.